96 results on '"Grant, Charley"'
Search Results
2. Johnson & Johnson's Stock Deserves a Booster.
3. Vaccine Stocks Already Got Their Booster.
4. Amazon and Walmart Have an Rx for Healthcare. The Cure Won't Be Easy.
5. Johnson & Johnson Is a Picture of Health, Even Before Vaccine News.
6. Auto Investors Are Doing the Charleston.
7. This Wall Street Ritual Will Get Less Awful.
8. Teva Pharmaceutical: Value at Last.
9. Prepare to Lose a Bundle on Stocks Boosted by a Coronavirus Vaccine.
10. Down Is the New Up for Tesla Stock.
11. American Diners Have More Takeout in Their Future.
12. Table for None: Sysco Paints Dire Picture for Restaurants.
13. Betting on Health Care May Be Hazardous To Your Wealth.
14. Pharma's Future Blockbusters Laid Up With Coronavirus.
15. Cannabis Stocks Take a Hit.
16. No Happy Meal for Nutrisystem's Owner.
17. Domino's Surge Is Pie in the Sky.
18. Health-Care Stocks Won't Feel the Bern for Long: Any politics-fueled selloff will present buying opportunity.
19. Medical-Device Stocks Risk Short-Term Heartbreak: Medical-device stocks are hot, with valuations to match. Strong earnings are needed for the sector to maintain momentum.
20. Novavax Shareholders Inoculated for Exuberance: The flu-vaccine maker's shares have surged on news of a spreading coronavirus in China, but longtime shareholders are still nursing losses.
21. Dollar Tree Shortchanged by Tariffs, Crowded Field: Struggles with cost control, tariff threat leave discount retailer's shareholders a dollar short.
22. Investors Don’t Love Elanco’s New Tricks.
23. Merck Has a Good Problem and Plenty of Options.
24. Pfizer May Buy Low and Smart in Generics Gambit.
25. AbbVie and Big Pharma: No Miracle Cures.
26. Growth Is Worth Paying Up for at Pfizer.
27. Generics Lawsuit Is a Problem for All Health-Care Stocks.
28. Brother, Tesla Can’t Spare a Dime.
29. Investors are Sick of Health Insurance.
30. Shocks Are Piling up at Tesla.
31. How Many More Tears at Johnson & Johnson?
32. Another Bad Deal for Bayer.
33. The Downside of a United Technologies Breakup.
34. Pharma Stocks Soothe Stock-Market Malady.
35. Teva Passes Its Check-Up.
36. Biotech Is Down but Far From Out.
37. Animal-Health Stocks Will Continue to Shine.
38. How Two Musk Decisions in 2016 Put Tesla Into Trouble.
39. Why Mylan, Not Tesla, Is the Buyout to Bet On.
40. Tesla’s Big Number Doesn’t Solve Its Problems.
41. How Amazon Made Pharmacies Ill.
42. Why SoftBank and GM Make an Odd but Happy Couple.
43. Why It Is Harder to Diagnose Hospital Stocks.
44. It’s Still Deere’s Season.
45. Stocks Have an Earnings Problem.
46. Biotech Gets a Reality Check.
47. Tesla’s Model 3 Is No Model T.
48. The Clock Is Ticking Faster at Tesla.
49. Health Care ‘Tapeworm’ Faces New Threat.
50. AbbVie Gives More Juice to Drug Rally.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.